Prosecution Insights
Last updated: August 15, 2026

Arcutis Biotherapeutics Inc.

4 pending office actions • 2 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other4 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
75% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SOROUSH, LAYLA 2 40.4% +43.5%
ABDALHAMEED, MANAHIL MIRGHANI ALI 1 50.4% +40.1%
JOSEPH, JANET 1 40.0% +51.3%

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18827222 DOSING REGIMENS USING TOPICAL ROFLUMILAST COMPOSITIONS SOROUSH, LAYLA
18795580 LAURETH-4 CONTAINING TOPICAL FORMULATIONS ABDALHAMEED, MANAHIL MIRGHANI ALI
18627861 TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS SOROUSH, LAYLA
18037316 COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY JOSEPH, JANET

Top Art Units

Art UnitApps
1622 2
1611 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18827222 DOSING REGIMENS USING TOPICAL ROFLUMILAST COMPOSITIONS SOROUSH, LAYLA 1622 §103DP Final Rejection Pending Sep 06, 2024
18795580 LAURETH-4 CONTAINING TOPICAL FORMULATIONS ABDALHAMEED, MANAHIL MIRGHANI ALI §103DP Non-Final OA Pending Aug 06, 2024
18627861 TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS SOROUSH, LAYLA 1622 §102§103DP Non-Final OA Pending Apr 05, 2024
18037316 COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY JOSEPH, JANET 1611 §102§103DP Non-Final OA Pending May 16, 2023

Managing Arcutis Biotherapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month